Rimonabant
Rimonabant was not approved by the FDA due to concerns about suicidal tendencies in patients. Sanofi-Aventis had hoped to release Rimonabant as a weight loss drug.
History - Rimonabant review: Acomplia for Quit Smoking Treatment
This displays a history of all member actions taken on this element.
You can view the details of an action and in some cases reverse it.
Page 1 (of 1)
| Title | Action | Member | Date | View |
|---|---|---|---|---|
|
|
Details
|
